MedTrace Logo

Patient Education and Rheumatoid Arthritis

NCT07170371 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 88

Last updated 2025-09-12

No results posted yet for this study

Summary

The goal of this clinical trial is to learn if a culturally adapted patient education program can help people with rheumatoid arthritis (RA) manage their disease and improve their quality of life. The main questions it aims to answer are:

* Does the program improve patients' knowledge, self-management skills, and confidence in dealing with RA?
* Does it lead to better quality of life and treatment adherence compared to usual care?

Participants will:

* Join group sessions and individual activities focused on RA education, self-care, and stress management
* Take part in the program for 6 months, with regular follow-up visits
* Complete questionnaires about symptoms, daily activities, and quality of life

Conditions

Interventions

OTHER

patient education

A culturally adapted patient education program designed for individuals with rheumatoid arthritis. The program was developed through a structured needs assessment and based on established health behavior theories. It includes five core modules delivered over six months: understanding rheumatoid arthritis, monitoring disease activity, treatment strategies, nutrition, and stress management. Sessions combine group workshops and individual support, with interactive materials and practical exercises. The program aims to strengthen patients' knowledge, self-management skills, and quality of life compared to usual care.

OTHER

Usual Care

patients will receive usual care only

Sponsors & Collaborators

  • Hassan II University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-09-05
Primary Completion
2025-09-30
Completion
2026-03-30

Countries

  • Morocco

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07170371 on ClinicalTrials.gov